Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

The British drugmaker’s unit RBP Global Holdings Ltd. signed up with Piper Sandler Finance LLC and certain buyers for $400 ...

Fintel reports that on November 4, 2024, Piper Sandler initiated coverage of Nektar Therapeutics (NasdaqCM:NKTR) with a ...

In a report released today, Matthew Farrell CFA from Piper Sandler reiterated a Hold rating on Vivid Seats (SEAT – Research Report), with ...

Piper Sandler initiated coverage of Nektar (NKTR) with an Overweight rating and $7 price target The analyst believes Nektar’s lead asset ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

Ann Miller will lead global sports marketing, and Chief Supply Chain Officer Venkatesh Alagirisamy will be elevated to the ...

On Thursday, Karyopharm Therapeutics Inc (KPTI) stock saw a modest uptick, ending the day at $0.99 which represents a slight increase of $0.15 or 17.86% from the prior close of $0.84. The stock opened ...

Microsoft stock fell after guidance disappointed investors. Analysts see strong demand and AI revenue opportunities for the future.

On Monday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.63 which represents a slight increase of $0.04 or 2.52% from the prior close of $1.59. The stock opened at $1.

We recently compiled a list of the 10 AI News Investors Should Not Miss. In this article, we are going to take a look at ...

Boston Beer (NYSE:SAM – Free Report) had its price objective boosted by Piper Sandler from $325.00 to $330.00 in a research ...